(Q53185402)

English

A new clue to explain resistance to mTOR inhibitors.

scientific article published in March 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

title

A new clue to explain resistance to mTOR inhibitors. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

author

Shile Huang

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

publication date

1 March 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

published in

Cell Cycle

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

page(s)

844

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

cites work

mTOR: from growth signal integration to cancer, diabetes and ageing

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

Updates of mTOR inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.4161%2FCC.11.5.19598

retrieved

21 January 2018

Identifiers

DOI

10.4161/CC.11.5.19598

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

PubMed publication ID

22336918

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22336918

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/22336918

ResearchGate publication ID

221834719

0 references

(Q53185402)

A new clue to explain resistance to mTOR inhibitors.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)